Position Paper / European Policy

 

Use of Animals in Cystic Fibrosis Medical Research

The Danish Cystic Fibrosis Association is well aware of public concerns about the use of animals in medical research. However, the appropriate and responsible use of animals is an indispensable part of biomedical research in general. Therefore, we support this use.

In the 1960's barely half of those with CF reached their school age. Since then the life expectancy for CF-patients has increased remarkably. At present many CF patients reach adulthood, receive educations, obtain jobs, have families and even children of their own. This has only been possible as a result of huge research efforts in drugs and treatment for CF involving animal use in research. So far the use of animals in CF research has represented the way foreward to better treatment, survival and quality of life for CF-patients.


The 3 R's

All medical research involving animals should reflect the longstanding guiding principles of the so-called 3 R's: Replacement of animals by non-animal methods where possible; the Reduction of numbers to a minimum level to obtain valid results where replacement is not possible and Refinement of all procedures to minimise adverse effects.

In this context, we strongly support European and international initiatives which foster the implementation of the 3 R's without impeding pharmaceutical research and medical progress for CF-patients.


Genetically modified animals in research

Genetic approaches are indispensable to enchance our knowledge and understanding of disease. Therefore, we also support the use of genetically modified animals in CF-research.

In 1993 genetically modified CF mice were used in CF gene therapy research. CF mice have also been used to identify 'modifer' genes in CF explaining there are differeneces in the severity of symptomes of CF-patients. Research and understanding of the CF-gene has developed rapidly in recent years helping scientists to identify numerous approches in which gene and drug therapy may be attemped in CF. To screen all approaches in CF-patients would take decades while CF-patients are still dying prematurely because from their disease. CF mice allow rapid identification of treatments that show most promise and thereby significantly reduce the timescale in CF-research and maybe safe the lives of the patients suffering from CF. 


At present - there is no alternative to use of animals in research

Established alternatives to the use of animals in CF-research, including cell culture and computer models, allow a limited part of an organism to be studied. These methods are very useful for studies on particular organs and help considerably to limit the number of

animals used in medical experiments. We encourage all researchers to develop such alternatives  whenever possible. However, we feel strongly that before any non-animal alternative method is adopted, it must be proven to be a true substitute, capable of

provinding researchers with data comparable in safety, efficacy, quality, reliability and validity to those curently avaliable through the use of animals.

Until this is fully demonstrated, we cannot support the elimination of animals use in CF research, because it will hamper and reduce the treatment and quality of life for our patients.

 

24 May 2005
Danish Cystic Fibrosis Association